Banco Santander, S.A. (LON:BNC)

Revance Therapeutics Revenue

Banco Santander had revenue of 10.59B EUR in the quarter ending June 30, 2025, a decrease of -15.83%. This brings the company's revenue in the last twelve months to 49.95B, up 2.09% year-over-year. In the year 2024, Banco Santander had annual revenue of 50.80B with 10.97% growth.

• Revenue (ttm): 49.95B EUR
• Revenue Growth: +2.09%
• P/S Ratio: 2.18
• Revenue / Employee: 241.60K EUR
• Employees: 206,753
• Market Cap: 93.33B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	50.80B	5.02B	10.97%
Dec 31, 2023	45.78B	3.83B	9.13%
Dec 31, 2022	41.95B	2.94B	7.54%
Dec 31, 2021	39.01B	7.17B	22.51%
Dec 31, 2020	31.84B	-9.10B	-22.22%